ArticleSisli Etfal Hastanesi tip bulteni2025
Clinical, Radiological and Hormonal Characteristics of Our Patients with Primary Empty Sella: A Single-Centre Experience.
Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: A common incidental radiological finding in asymptomatic adults is primary empty sella (PES). We examined the clinical, radiological and hormonal features of patients with PES to identify risk factors and guide follow-up strategies. Methods: The study included 120 patients with PES. Data on patients was obtained retrospectively and included details on symptoms, diseases, as well as radiological, biochemical and hormonal findings. Patients were divided into two groups (partial and total) according to sella turcica cerebrospinal fluid volume and pituitary height. They were also classified as having isolated hormone deficiency (HD), hypopituitarism or panhypopituitarism according to the severity of pituitary insufficiency. Results: HD was found in 83.3% of the study group. The most common causes were growth hormone deficiency and central hypogonadism. The two groups were indistinguishable with regard to pituitary insufficiency; however, panhypopituitarism was more prevalent in the total PES group (60.5% vs 30.5%). PES was more common in women, while both general and severe HD were more common in men. Pituitary height was positively correlated with thyroid stimulating hormone, free T4, insulin-like growth factor-1, testosterone, estradiol, adrenocorticotropic hormone and cortisol (r=0.275, p=0.002; r=0.277, p=0.002; r=0.394, p<0.001; r=0.319, p<0.001; r=0.195, p=0.032; r=0.220, p=0.016; r=0.310, p=0.001). Low pituitary height and male gender were associated with an increased risk of panhypopituitarism (p=0.002 vs p=0.015). Conclusion: Pituitary insufficiency is common in PES, but panhypopituitarism is more common in total PES. Low pituitary height and male gender are risk factors for panhypopituitarism. Patients with these characteristics should be monitored more closely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.